Crinecerfont, a CRF(1) Receptor Antagonist, Lowers Adrenal Androgens in Adolescents With Congenital Adrenal Hyperplasia

CONTEXT: Crinecerfont, a corticotropin-releasing factor type 1 receptor antagonist, has been shown to reduce elevated adrenal androgens and precursors in adults with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD), a rare autosomal recessive disorder characterized by co...

Descripción completa

Detalles Bibliográficos
Autores principales: Newfield, Ron S, Sarafoglou, Kyriakie, Fechner, Patricia Y, Nokoff, Natalie J, Auchus, Richard J, Vogiatzi, Maria G, Jeha, George S, Giri, Nagdeep, Roberts, Eiry, Sturgeon, Julia, Chan, Jean L, Farber, Robert H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583973/
https://www.ncbi.nlm.nih.gov/pubmed/37216921
http://dx.doi.org/10.1210/clinem/dgad270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583973/
https://www.ncbi.nlm.nih.gov/pubmed/37216921
http://dx.doi.org/10.1210/clinem/dgad270

Ejemplares similares